Conferences
15–16 February 2018, Manchester, UK
3th Annual Biomarkers Congress – Focused on Immuno Oncology, Neuroscience, Respiratory, Metabolic and Cardiovascular Diseases, etc
Over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
Over 55 presentations, case studies, novel technologies, round-table and panel discussions focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials.